RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Public ClinicalTrials.gov record NCT07002034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Adjustment Disorder in Patients With Cancer and Other Medical Illnesses
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.
Study identification
- NCT ID
- NCT07002034
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2025
- Primary completion
- Oct 31, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Aug 23, 2026
2025 – 2026
United States locations
- U.S. sites
- 32
- U.S. states
- 25
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB, Psychiatry and Behavioral Neurology | Birmingham | Alabama | 35209 | Recruiting |
| University of Arizona | Tucson | Arizona | 85724 | Recruiting |
| Kadima Neuropsychiatry Institute | San Diego | California | 92037 | Recruiting |
| Providence Medical Foundation | Santa Rosa | California | 95403 | Recruiting |
| University of Colorado | Aurora | Colorado | 80045 | Recruiting |
| University of South Florida, Department of Psychiatry and Behavioral Neuroscience | Tampa | Florida | 33613 | Recruiting |
| Emory University | Atlanta | Georgia | 30329 | Recruiting |
| Hawaii Pacific Neuroscience | Honolulu | Hawaii | 96817 | Recruiting |
| Rush University Medical Center | Chicago | Illinois | 60612 | Recruiting |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | Recruiting |
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | Recruiting |
| LSU Health Shreveport | Shreveport | Louisiana | 71103 | Recruiting |
| Sunstone Therapies, PC | Rockville | Maryland | 20850 | Recruiting |
| Sheppard Pratt | Towson | Maryland | 21204 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| University of Massachusetts Chan Medical Center | Worcester | Massachusetts | 01655 | Recruiting |
| University of Michigan | Ann Arbor | Michigan | 48109 | Recruiting |
| Henry Ford Health | Novi | Michigan | 48377 | Recruiting |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | Recruiting |
| University of New Mexico, School of Medicine | Albuquerque | New Mexico | 87131 | Recruiting |
| Roswell Park Center Institute | Buffalo | New York | 14263 | Recruiting |
| NYU Langone Health | New York | New York | 10016 | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27514 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44113 | Recruiting |
| The Ohio State University, Department of Psychiatry | Columbus | Ohio | 43210 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Alliance for Multispecialty Research Clinical | Knoxville | Tennessee | 37920 | Recruiting |
| Dell Medical School, University of Texas at Austin | Austin | Texas | 78712 | Recruiting |
| Cedar Clinical Research Inc. | Draper | Utah | 84020 | Recruiting |
| UVA Center for Psychiatric Clinical Research | Charlottesville | Virginia | 22903 | Recruiting |
| Seattle Neuropsychiatric Treatment Center | Seattle | Washington | 98104 | Recruiting |
| University of Wisconsin at Madison | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07002034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07002034 live on ClinicalTrials.gov.